Liminatus Pharma Class A Common Stock Statistics Share Statistics Liminatus Pharma Class A Common Stock has 27.06M
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding 27.06M Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares 262 FTD / Avg. Volume 0.02%
Short Selling Information The latest short interest is 261.52K, so 0% of the outstanding
shares have been sold short.
Short Interest 261.52K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -12.41 and the forward
PE ratio is null.
Liminatus Pharma Class A Common Stock's PEG ratio is
-0.07.
PE Ratio -12.41 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio -2.27 P/FCF Ratio -11.6 PEG Ratio -0.07
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Liminatus Pharma Class A Common Stock.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.09,
with a Debt / Equity ratio of -0.32.
Current Ratio 0.09 Quick Ratio 0.09 Debt / Equity -0.32 Debt / EBITDA -1.86 Debt / FCF -1.65 Interest Coverage -21.04
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-968.1K Employee Count 3 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 18.84K Effective Tax Rate -0.65%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 0.47, so Liminatus Pharma Class A Common Stock's
price volatility has been higher than the market average.
Beta 0.47 52-Week Price Change n/a 50-Day Moving Average 3.72 200-Day Moving Average n/a Relative Strength Index (RSI) 37.11 Average Volume (20 Days) 1,452,339
Income Statement
Revenue n/a Gross Profit n/a Operating Income -2.91M Net Income -2.9M EBITDA -2.75M EBIT -2.75M Earnings Per Share (EPS) -0.4
Full Income Statement Balance Sheet The company has 804.54K in cash and 5.12M in
debt, giving a net cash position of -4.32M.
Cash & Cash Equivalents 804.54K Total Debt 5.12M Net Cash -4.32M Retained Earnings -17.52M Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -3.11M
and capital expenditures 0, giving a free cash flow of -3.11M.
Operating Cash Flow -3.11M Capital Expenditures n/a Free Cash Flow -3.11M FCF Per Share -0.43
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
